"cancer immunotherapy" trang 7 - tải miễn phí từ tailieunhanh
A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma

A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma
16    7    1
Cognitive assessment in patients treated by immunotherapy: The prospective Cog-Immuno trial

Cognitive assessment in patients treated by immunotherapy: The prospective Cog-Immuno trial
9    10    1
Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
15    1    1
Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: A systematic review and network Meta-analysis

Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: A systematic review and network Meta-analysis
12    1    1
The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma
11    1    1
Lung erosion following adjuvant immunotherapy with pembrolizumab: A case report

Lung erosion following adjuvant immunotherapy with pembrolizumab: A case report
4    14    1
Failure of immunological cells to eradicate tumor and cancer cells: An overview

Failure of immunological cells to eradicate tumor and cancer cells: An overview
14    91    0
Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer

Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer
11    63    0
Immunotherapy for non-small cell lung cancers: Biomarkers for predicting responses and strategies to overcome resistance

Immunotherapy for non-small cell lung cancers: Biomarkers for predicting responses and strategies to overcome resistance
10    50    1
The TRIPLEX study: Use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer

The TRIPLEX study: Use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer
8    1    1
Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors

Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
8    1    1
Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils

Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils
11    1    1
Immunotherapy: A novel approach to fight cancer

Immunotherapy: A novel approach to fight cancer
14    71    1
Immunotherapy and associated immunerelated adverse events at a large UK centre: A mixed methods study

Immunotherapy and associated immunerelated adverse events at a large UK centre: A mixed methods study
11    78    1
Durvalumab for extensive stage of small-cell lung cancer with lambert-eaton myasthenic syndrome

Durvalumab for extensive stage of small-cell lung cancer with lambert-eaton myasthenic syndrome
5    6    1
Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
7    1    1
Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective

Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective
537    95    0
Controlling Cancer in Developing Countries - Prevention and Treatment Strategies Merit Further Study

Controlling Cancer in Developing Countries - Prevention and Treatment Strategies Merit Further Study
4    56    0
Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia
11    65    0
Activity of PD1 inhibitor therapy in advanced sarcoma: A single-center retrospective analysis

Activity of PD1 inhibitor therapy in advanced sarcoma: A single-center retrospective analysis
11    92    1